- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
SOLID TUMORS
OmniSeq INSIGHT® is a comprehensive genomic and immune profiling test validated for all solid tumors. Next generation sequencing interrogates 523 genes for mutations, 4 copy number alterations and 55 fusions/splice variants, measures expression of 64 immune genes, and determines microsatellite instability (MSI) and tumor mutational burden (TMB). Immunohistochemistry determines PD-L1 expression. The test informs treatment decisions, including targeted and immunotherapy options, eligibility for clinical trials, and mechanisms of therapy resistance based on the genomic and immune profile of a patient’s tumor.
Labcorp Oncology
3 Forest Parkway
Shelton, CT 06484
Fax: 212-698-9532
Call Client Services at
800-447-5816
Online ordering and result reporting